ARKG ARK Genomic Revolution ETF
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| ARKG | -11.5% | -3.1% | +48.3% | +58.9% | +21.7% | -9.7% |
| Equity average (4725 funds) | -2.0% | +2.6% | +2784.8% | +64227.1% | +13.9% | +1.4% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$149K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| IAM IAMBIC THERAPEUTICS INC | 1.29% | $11.5M | $0 |
Holdings · as of Nov 12, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | TEM TEMPUS AI INC-CL A | 10.69% |
| 2 | TXG 10X GENOMICS INC-CLASS A | 7.90% |
| 3 | TWST TWIST BIOSCIENCE CORP | 7.65% |
| 4 | ABSI ABSCI CORP | 5.29% |
| 5 | CRSP CRISPR THERAPEUTICS AG | 5.23% |
| 6 | GH GUARDANT HEALTH INC | 4.85% |
| 7 | LLY ELI LILLY & CO | 4.47% |
| 8 | NTRA NATERA INC | 4.36% |
| 9 | ILMN ILLUMINA INC | 4.29% |
| 10 | BEAM BEAM THERAPEUTICS INC | 4.00% |
| 11 | SDGR SCHRODINGER INC | 3.68% |
| 12 | CDNA CAREDX INC | 3.54% |
| 13 | RXRX RECURSION PHARMACEUTICALS-A | 2.85% |
| 14 | ADPT ADAPTIVE BIOTECHNOLOGIES | 2.84% |
| 15 | CMPS COMPASS PATHWAYS PLC | 2.64% |
| 16 | VCYT VERACYTE INC | 2.24% |
| 17 | NRIX NURIX THERAPEUTICS INC | 2.19% |
| 18 | PRME PRIME MEDICINE INC | 2.09% |
| 19 | NTLA INTELLIA THERAPEUTICS INC | 1.93% |
| 20 | ALMR ALAMAR BIOSCIENCES INC | 1.84% |
| 21 | BFLY BUTTERFLY NETWORK INC | 1.82% |
| 22 | WGS GENEDX HOLDINGS CORP | 1.65% |
| 23 | ARCT ARCTURUS THERAPEUTICS HOLDIN | 1.42% |
| 24 | IAM IAMBIC THERAPEUTICS INC | 1.29% |
| 25 | IONS IONIS PHARMACEUTICALS INC | 1.28% |
| 26 | PACB PACIFIC BIOSCIENCES OF CALIF | 1.26% |
| 27 | SCTX SCRIBE THERAPEUTICS INC | 1.21% |
| 28 | GENB GENERATE BIOMEDICINES INC | 1.10% |
| 29 | FRNM FREENOME INC | 1.03% |
| 30 | MASS 908 DEVICES INC | 1.03% |
| 31 | CERS CERUS CORP | 0.85% |
| 32 | KYMR KYMERA THERAPEUTICS INC | 0.82% |
| 33 | QSI QUANTUM-SI INC | 0.46% |
| 34 | ARKG GOLDMAN FS TRSY OBLIG INST 468 | 0.21% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 29, 2021 | $0.3824 |
| Dec 29, 2020 | $0.7901 |
| Dec 27, 2019 | $1.0539 |
| Dec 27, 2018 | $0.4663 |
| Dec 27, 2017 | $0.3277 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in ARKG in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error